NEW YORK, Aug. 4, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. (“Mersana” or the “Company”) (NASDAQ: MRSN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
